ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 261 out of 2429

$415K Total Retail Price of All Prescriptions

Rank: 411 out of 2429

502 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,410 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 480 453 1 1
FUROSEMIDE 311 285 2 5
OMEPRAZOLE 273 223 3 7
LEVOTHYROXINE SODIUM 261 243 4 3
LISINOPRIL 242 215 5 2
TRIAMTERENE-HCTZ 238 228 6 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 203 7 27
HYDROCODONE-ACETAMINOPHEN 226 132 S3 7 6
AMLODIPINE BESYLATE 219 218 9 4
METFORMIN HCL 211 180 10 8
METOPROLOL TARTRATE 189 172 11 9
METOPROLOL SUCCINATE 167 165 12 12
WARFARIN SODIUM 164 151 13 11
PRAVASTATIN SODIUM 158 147 14 16
GLIMEPIRIDE 143 123 15 51
FENOFIBRATE 139 120 16 48
POTASSIUM CHLORIDE 134 129 17 14
DONEPEZIL HCL 133 133 18 26
CITALOPRAM HBR 132 116 19 19
ZOLPIDEM TARTRATE 126 101 20 28
GABAPENTIN 124 98 21 18
CARVEDILOL 99 83 22 21
ATORVASTATIN CALCIUM 96 86 23 13
TAMSULOSIN HCL 95 95 24 29
BENAZEPRIL HCL 87 87 25 80
PANTOPRAZOLE SODIUM 86 82 26 34
OXYBUTYNIN CHLORIDE ER 85 77 27 79
TRAMADOL HCL 85 64 27 17
NAMENDA 82 82 29 35
ATENOLOL 77 69 30 15
ALENDRONATE SODIUM 77 77 30 20
MELOXICAM 74 70 32 40
LOSARTAN POTASSIUM 73 55 33 22
DIGOXIN 71 71 34 43
CLOPIDOGREL 68 67 35 31
PLAVIX 68 64 35 44
FLUOXETINE HCL 67 47 37 61
AZITHROMYCIN 67 59 37 46
HYDROCHLOROTHIAZIDE 65 63 39 10
ALLOPURINOL 64 64 40 33
AMLODIPINE BESYLATE-BENAZEPRIL 64 64 40 85
LOVASTATIN 63 63 42 30
ESCITALOPRAM OXALATE 60 57 43 74
CLONIDINE HCL 57 41 44 68
IPRATROPIUM-ALBUTEROL 57 57 44 120
NEXIUM 57 57 44 37
CYMBALTA 53 15 47 58
PAROXETINE HCL 53 53 47 67
PROAIR HFA 50 40 49 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.